CAS Medical Systems
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of CAS Medical Systems generated cash of -$2,598,115, which is more than the previous year. Cash used in financing activities reached the amount of $1,115,435 last year. Net change in cash is therefore -$2,380,997.
Cash Flow
| 2010 | 2.53B | -960.05M | -2.55B |
|---|---|---|---|
| 2011 | -3.60M | -3.75M | 13.88M |
| 2012 | -5.11M | -436.62K | 3.40M |
| 2013 | -8.74M | 246.48K | 7.43M |
| 2014 | -5.25M | -1.61M | 3.17M |
| 2015 | -3.90M | -285.45K | 7.22M |
| 2016 | -4.56M | 2.38M | 143.84K |
| 2017 | -4.67M | 5.05M | -215.19K |
| 2018 | -2.59M | -898.31K | 1.11M |
CASM Cash Flow Statement (2010 – 2018)
| 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 5.65M | 5.48M | 7.52M | 4.49M | 8.19M | 9.24M | 11.38M | 4.49M | 1.18B |
Operating activities | |||||||||
Net income | -5.96M | -2.33M | -3.16M | -6.89M | -7.60M | -10.36M | -7.30M | -6.08M | -1.30B |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 1.55M | 1.28M | 1.36M | 1.44M | 1.85M | 1.45M | 1.09M | 888.26K | 960.45M |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 933.44K | 894.71K | 870.09K | 338.68M |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 933.44K | 894.71K | 870.09K | 338.68M |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | 263.87K | 151.96K | -400.68K | 450.87K | -1.00M | -242.55K | 284.86K | 71.28K | 708.41M |
Inventories | -64.66K | -297.60K | 167.24K | -655.00K | 572.09K | -387.68K | -266.75K | 1.53M | 969.67M |
Accounts payable | 1.23M | -313.83K | 21.62K | 370.23K | -312.51K | -178.79K | 748.39K | -409.38K | 556.40M |
Cash generated by operating activities | -2.59M | -4.67M | -4.56M | -3.90M | -5.25M | -8.74M | -5.11M | -3.60M | 2.53B |
Investing activities | |||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -783.48K | -596.38K | -1.26M | -1.12M | -1.50M | -1.23M | -1.56M | -1.11M | -875.11M |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -898.31K | 5.05M | 2.38M | -285.45K | -1.61M | 246.48K | -436.62K | -3.75M | -960.05M |
Financing activities | |||||||||
Common Stock Issued | 58.64K | 18.89K | 42.42K | 8.67M | 122.27K | 5.95M | 52.61K | 58.73K | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -3.27M | -5.65M | -5.48M | -7.52M | -4.49M | -8.19M | -9.24M | -11.38M | 0 |
Repayments of term debt | 0 | 0 | -7.28M | 0 | -291.31K | -11.5K | -147.93K | -40.38M | -1.70B |
Cash used in financing activities | 1.11M | -215.19K | 143.84K | 7.22M | 3.17M | 7.43M | 3.40M | 13.88M | -2.55B |
Net Change In Cash | -2.38M | 164.29K | -2.03M | 3.03M | -3.69M | -1.05M | -2.14M | 6.89M | 3.30B |
Cash at end of period | 3.27M | 5.65M | 5.48M | 7.52M | 4.49M | 8.19M | 9.24M | 11.38M | 4.49B |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |